GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cleveland BioLabs Inc (NAS:CBLI) » Definitions » Long-Term Capital Lease Obligation

Cleveland BioLabs (Cleveland BioLabs) Long-Term Capital Lease Obligation : $0.00 Mil (As of Mar. 2021)


View and export this data going back to 2006. Start your Free Trial

What is Cleveland BioLabs Long-Term Capital Lease Obligation?

Cleveland BioLabs's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2021 was $0.00 Mil.


Cleveland BioLabs Long-Term Capital Lease Obligation Historical Data

The historical data trend for Cleveland BioLabs's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cleveland BioLabs Long-Term Capital Lease Obligation Chart

Cleveland BioLabs Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cleveland BioLabs Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cleveland BioLabs  (NAS:CBLI) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Cleveland BioLabs Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Cleveland BioLabs's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Cleveland BioLabs (Cleveland BioLabs) Business Description

Industry
Traded in Other Exchanges
N/A
Address
73 High Street, Buffalo, NY, USA, 14203
Cleveland BioLabs Inc is a biopharmaceutical company. The company is developing novel approaches to activate the immune system and address serious medical needs. Its proprietary platform of Toll-like immune receptor activators has applications in the mitigation of radiation injury and immuno-oncology. Its lead product candidate is entolimod, an immuno-stimulatory agent, which is developed as a radiation countermeasure and immunotherapy for oncology and other indications. Entolimod is a Toll-like receptor 5 (TLR5) agonist, which is developed as a radiation countermeasure for the prevention of death from Acute Radiation Syndrome (ARS), and as an oncology drug.
Executives
Christopher Zosh officer: Vice President of Finance C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO NY 14203
Ivan Fedyunin director 73 HIGH STREET, BUFFALO NY 14203
John Edward Szydlo officer: Principal Financial Officer 73 HIGH STREET, BUFFALO NY 14203
Randy S. Saluck director C/O CLEVELAND BIOLABS, INC., 73 HIGH STREET, BUFFALO NY 14203
Alexander Andryushechkin director 73 HIGH STREET, BUFFALO NY 14203
Daniil Talyanskiy director 73 HIGH STREET, BUFFALO NY 14203
Alexey Nechaev director 73 HIGH STREET, BUFFALO NY 14203
Lea Verny director 73 HIGH STREET, BUFFALO NY 14203
Tatiana Levina director 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031
Ivan Persiyanov director 4 SADOVNICHESKAYA ST, MOSCOW 1Z 115035
Anna Evdokimova director 9-96 UNIVERSITETSKIY PROSPEKT, MOSCOW 1Z 119296
Yulia Lebedina director 5 MALYSHEVA STREET, FLAT 7, MOSCOW 1Z 109129
Konstantin Gorshkov director 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031
Natalia Saraeva director 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031
Natalia Khudyk director 10-12 EMMANOUIL ROIDI STR, LIMASSOL G4 CY3031

Cleveland BioLabs (Cleveland BioLabs) Headlines